Direct and indirect control of orexin/hypocretin neurons by glycine receptors

J Physiol. 2011 Feb 1;589(Pt 3):639-51. doi: 10.1113/jphysiol.2010.198457. Epub 2010 Dec 6.

Abstract

Hypothalamic hypocretin/orexin (hcrt/orx) neurons promote arousal and reward seeking, while reduction in their activity has been linked to narcolepsy, obesity and depression. However, the mechanisms influencing the activity of hcrt/orx networks in situ are not fully understood. Here we show that glycine, a neurotransmitter best known for its actions in the brainstem and spinal cord, elicits dose dependent postsynaptic Cl⁻ currents in hcrt/orx cells in acute mouse brain slices. The effect was blocked by the glycine receptor (GLyR) antagonist strychnine and mimicked by the GlyR agonist alanine. Postsynaptic GlyRs on hcrt/orx cells remained functional during both early postnatal and adult periods, and gramicidin-perforated patch-clamp recordings revealed that they progressively switch from excitatory to inhibitory during the first two postnatal weeks. The pharmacological profile of the glycine response suggested that developed hcrt/orx neurons contain α/β-heteromeric GlyRs that lack α2-subunits, whereas α2-subunits, whereas α2-subunits are present in early postnatal hcrt/orx neurons. All postsynaptic currents (PSCs) in developed hcrt/orx cells were blocked by inhibitors of GABA and glutamate receptors, with no evidence of GlyR-mediated PSCs. However, the frequency but not amplitude of miniature PSCs was reduced by strychnine and increased by glycine in ~50% of hcrt/orx neurons. Together, these results provide the first evidence for functional GlyRs in identified hcrt/orx circuits and suggest that the activity of developed hcrt/orx cells is regulated by two GlyR pools: inhibitory extrasynaptic GlyRs located on all hcrt/orx cells and excitatory GlyRs located on presynaptic terminals contacting some hcrt/orx cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Aging / physiology
  • Alanine / pharmacology
  • Animals
  • Animals, Newborn
  • Benzothiadiazines / pharmacology
  • Chloride Channels / physiology
  • Electrophysiological Phenomena / drug effects
  • Electrophysiological Phenomena / physiology
  • GABA Antagonists / pharmacology
  • Glutamic Acid / metabolism
  • Glycine / pharmacology
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • Hypothalamus / drug effects
  • Hypothalamus / growth & development
  • Hypothalamus / physiology
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Mice
  • Mice, Transgenic
  • Neurons / drug effects
  • Neurons / physiology*
  • Neuropeptides / metabolism*
  • Orexins
  • Patch-Clamp Techniques
  • Picrotoxin / pharmacology
  • Pyridazines / pharmacology
  • Receptors, GABA / physiology
  • Receptors, Glutamate / physiology
  • Receptors, Glycine / antagonists & inhibitors
  • Receptors, Glycine / physiology*
  • Strychnine / pharmacology
  • Synaptic Potentials / drug effects
  • Synaptic Potentials / physiology
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Benzothiadiazines
  • Chloride Channels
  • GABA Antagonists
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins
  • Pyridazines
  • Receptors, GABA
  • Receptors, Glutamate
  • Receptors, Glycine
  • enhanced green fluorescent protein
  • Picrotoxin
  • Green Fluorescent Proteins
  • Glutamic Acid
  • gamma-Aminobutyric Acid
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • gabazine
  • Strychnine
  • Alanine
  • cyclothiazide
  • Glycine